Clinical Trial Details

EORTC-10085-BCG

Back to Clinical Trials Database

Clinical and biological characterization of Male Breast Cancer : an international retrospective EORTC, BIG and NABCG intergroup study (for the prospective part, please refer to 10085p)

Study documentation

Trial Status LT-FU ongoing
Dates Date of activation: 27-Dec-2010
Date Step1 close: 03-Sep-2013
Data management at EORTC Yes
Design Cohort
Randomized open label
Targeted Sample size EORTC Groups: 1800 - All Groups: 1800
Treatment
Study Staff Fatima Cardoso (Study Coordinator) , Champalimaud Clinical Center, Lisboa
Sharon Hermes Giordano (Study Coordinator) , The University of Texas MD Anderson Cancer Center, Houston
Melanie Beauvois (Clinical Operations Manager) , EORTC Headquarters, Brussels
Ruxandra Dionisie (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels
Coralie Poncet (Statistician) , EORTC Headquarters, Brussels
Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Type of cancer Breast
Participating groups EORTC Breast Cancer Group
Swedish Association of Breast Oncologists
Breast International Group
Schweizerisches Arbeitsgemeinschaft Klin. Krebsforschung
Borstkanker Onderzoek Group Nederland
Cancer Trials Ireland
Recruiting centers AZ Damiaan (Oostende, Belgium)
AZ Groeninge – Oncology Centre (Kortrijk, Belgium)
CHU Helora Pole Hospitalier Jolimont - Hopital Jolimont (Haine-Saint-Paul, Belgium)
CHU Site Sainte-Elisabeth-UCL Namur (Namur, Belgium)
Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland)
Cliniques Universitaires Saint-Luc (Brussels, Belgium)
Cork University Hospital (Cork, Ireland)
Dana-Farber Cancer Institute & Harvard Medical School (Boston, United States of America)
Eastbourne District General Hospital (Eastbourne, United Kingdom)
Fred Hutchison Seattle Cancer Care Alliance (Seattle, United States of America)
Hopital du Valais - Hopital de Sion (Sion, Switzerland)
Hospital Universitari Vall d’Hebron -Vall d'Hebron Institut Oncologia (Barcelona, Spain)
Inselspital (Bern, Switzerland)
Institut Jules Bordet (Anderlecht, Belgium)
Kantonsspital Baden (Baden, Switzerland)
Kantonsspital Baselland - Bruderholz (Bruderholz, Switzerland)
Kantonsspital Baselland - Liestal (Liestal, Switzerland)
Kantonsspital St Gallen (St Gallen, Switzerland)
Kantonsspital Winterthur (Winterthur, Switzerland)
Luzerner Kantonsspital (Luzern, Switzerland)
Mater Misericordia University Hospital (Dublin, Ireland)
Medical University Of Gdansk (Gdansk, Poland)
Memorial Sloan-Kettering Cancer Center - Memorial hospital (New York, United States of America)
NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital (Glasgow, United Kingdom)
NHS Lothian - Western General Hospital (Edinburgh, United Kingdom)
North Tees and Hartlepool NHS Foundation Trust - University Hospital of North Tees (Stockton on Tees, United Kingdom)
Oncology Institute of Southern Switzerland - Ospedale Beata Vergine (Mendrisio, Switzerland)
Royal Sussex County Hospital (Brighton, United Kingdom)
Sonnenhofklinik Engeriedspital (Bern, Switzerland)
Spitalzentrum Biel (Biel, Switzerland)
St. Claraspital (Basel, Switzerland)
St. James'S Hospital (Dublin, Ireland)
St. Vincent'S University Hospital (Dublin 4, Ireland)
The University of Texas MD Anderson Cancer Center (Houston, United States of America)
Tumor- und BrustZentrum Ostschweiz (St Gallen, Switzerland)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
UniversitaetsSpital Zurich (Zurich, Switzerland)
Universitaetsspital Basel (Basel, Switzerland)
Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
University Hospital Waterford (Waterford, Ireland)
Worthing Hospital (Worthing - West Sussex, United Kingdom)
ZNA Jan Palfijn (Merksem, Belgium)
ZNA Middelheim (Antwerpen, Belgium)
Centers to be activated Mid Cheshire Hospitals NHS Foundation Trust - Leighton Hospital (Crewe, United Kingdom)
Radio-Onkologie Berner Oberland AG (Thun, Switzerland)
Protocol summary http://clinicaltrials.gov/study/NCT01101425
NCT number NCT01101425
Financial Support External Grant